US Patent Issued to EnGeneIC Molecular Delivery on Feb. 17 for "Compositions and vaccines for treating and/or preventing coronavirus variant infections and methods of using the same" (Australian Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,550, issued on Feb. 17, was assigned to EnGeneIC Molecular Delivery Pty Ltd (Sydney).

"Compositions and vaccines for treating and/or preventing coronavirus variant infections and methods of using the same" was invented by Himanshu Brahmbhatt (Sydney) and Jennifer MacDiarmid (Sydney).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to compositions and methods useful for treating, as well as vaccinating against, SARS-CoV-2 viral infections, including SARS-CoV-2 variant viral infections."

The patent was filed on July 21, 2022, under Application No. 17/870,536.

*For further information, including images, charts and tabl...